Visen Pharmaceuticals
IPOPublic · China · $150.0M raised
- Business Model
- B2B
- Total Funding
- $150.0M
- Last Round
- $150.0M Series BJan 2021
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Biopharmaceutical company (public)
Summary
Visen Pharmaceuticals is a Biotech company based in China. It has raised $150.0M in total across 1 round, most recently a $150.0M Series B round in Jan 2021. Investors include Sequoia China, OrbiMed and Sherpa Healthcare Partners.
Funding History
Mar 2025
Sign up to see all 2 events
Funding: Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/visen-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/visen-pharmaceuticals" alt="Visen Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>